sulfasalazine has been researched along with P carinii Pneumonia in 6 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the prophylactic effect of sulfasalazine against Pneumocystis jirovecii pneumonia (PJP) among rheumatoid arthritis (RA) patients." | 7.91 | Prophylactic effect of sulfasalazine against Pneumocystis pneumonia in patients with rheumatoid arthritis: A nested case-control study. ( Gosho, M; Nishino, J; Nunokawa, T; Shimada, K; Sugii, S; Tohma, S; Wagatsuma, Y; Yokogawa, N, 2019) |
| "Sulfasalazine use was associated with a decreased PCP risk (adjusted IRR <0." | 5.91 | Efficacy of sulfasalazine for the prevention of Pneumocystis pneumonia in patients with rheumatoid arthritis: A multicentric self-controlled case series study. ( Chen, FY; Chinen, N; Kimura, M; Nunokawa, T; Setoguchi, K; Shimada, K; Sugihara, M; Tateishi, M, 2023) |
| "To evaluate the prophylactic effect of sulfasalazine against Pneumocystis jirovecii pneumonia (PJP) among rheumatoid arthritis (RA) patients." | 3.91 | Prophylactic effect of sulfasalazine against Pneumocystis pneumonia in patients with rheumatoid arthritis: A nested case-control study. ( Gosho, M; Nishino, J; Nunokawa, T; Shimada, K; Sugii, S; Tohma, S; Wagatsuma, Y; Yokogawa, N, 2019) |
| "Sulfasalazine use was associated with a decreased PCP risk (adjusted IRR <0." | 1.91 | Efficacy of sulfasalazine for the prevention of Pneumocystis pneumonia in patients with rheumatoid arthritis: A multicentric self-controlled case series study. ( Chen, FY; Chinen, N; Kimura, M; Nunokawa, T; Setoguchi, K; Shimada, K; Sugihara, M; Tateishi, M, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Nunokawa, T | 3 |
| Chinen, N | 1 |
| Shimada, K | 3 |
| Kimura, M | 1 |
| Tateishi, M | 1 |
| Chen, FY | 1 |
| Setoguchi, K | 1 |
| Sugihara, M | 1 |
| Hoy, Z | 1 |
| Wright, TW | 2 |
| Elliott, M | 1 |
| Malone, J | 1 |
| Bhagwat, S | 1 |
| Wang, J | 2 |
| Gigliotti, F | 2 |
| Yokogawa, N | 2 |
| Sugii, S | 2 |
| Nishino, J | 1 |
| Gosho, M | 1 |
| Wagatsuma, Y | 1 |
| Tohma, S | 1 |
| Bhagwat, SP | 1 |
| George, TC | 1 |
| Khatchatourian, M | 1 |
| Seaton, TL | 1 |
6 other studies available for sulfasalazine and P carinii Pneumonia
| Article | Year |
|---|---|
Efficacy of sulfasalazine for the prevention of Pneumocystis pneumonia in patients with rheumatoid arthritis: A multicentric self-controlled case series study.
Topics: Arthritis, Rheumatoid; Humans; Methotrexate; Opportunistic Infections; Pneumocystis carinii; Pneumon | 2023 |
Combination Immunotherapy with Passive Antibody and Sulfasalazine Accelerates Fungal Clearance and Promotes the Resolution of
Topics: Animals; Anti-Inflammatory Agents; Antibodies; Cytokines; Female; Fungi; Immunologic Factors; Immuno | 2020 |
Effect of sulfasalazine use on the presence of Pneumocystis organisms in the lung among patients with rheumatoid arthritis: A test-negative design case-control study with PCR tests.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Lung; Male; Middle Aged; P | 2019 |
Prophylactic effect of sulfasalazine against Pneumocystis pneumonia in patients with rheumatoid arthritis: A nested case-control study.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Case-Control Studies; Databases, Factual; Female; | 2019 |
Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; CD4-Positive T-Lymphocytes; Cell Separation; Enzym | 2010 |
An unusual complication of immunosuppressive therapy in inflammatory bowel disease.
Topics: Aged; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antim | 1997 |